This activity is intended for internal CCAD Physicians

Activity Description:

This activity is based on the American College of Surgeons, Commission on Cancer standards. To meet the Commission on Cancer (CoC) standards for multidisciplinary cancer case conferences aka tumor boards cancer programs hold multidisciplinary cancer case conference(s) to evaluate patient management.

Target Audience: 

Hematology/Oncology, Nursing, Pathology, Pharmacology, Radiology

Learning Objectives:

• Demonstrate proficiency in staying up to date on the latest advancements in hematological malignancies research, treatment modalities, and evidence-based guidelines. This will be evident through the use of evidence-based practice guidelines and care pathways for hematological malignancies during tumor board meetings to develop personalized treatment plans for patients.
• Exhibit effective communication and collaboration skills within the malignant hematology tumor board setting to foster efficient and coordinated patient care. This includes articulating viewpoints clearly, actively listening to others, and engaging in respectful dialogue.
• Incorporate a patient-centered approach into the tumor board discussions. Participants will ensure patient preferences and values are considered when formulating treatment plans. Recognizing the importance of shared decision-making in the treatment planning process will enhance patient satisfaction and engagement.
• Remain informed about emerging strategies and technologies in hematologic malignancies by continually evaluating and incorporating these advancements into patient treatment plans, resulting in the highest quality and most effective care to patients.

Faculty Disclosure:

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi for Continuing Education mitigates all faculty conflicts of interest to ensure CME activities are free of commercial bias.

Activity Director(s): Wesam Ahmed, MD

The planning committee, faculty, and others in control of content (either individually or as a group) have NO relevant financial relationship(s) to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation Statement:

Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education.

Credit Designation:

This CME Activity is accredited with 1.00 AMA PRA Category 1 Credits™ Participants should claim only the credit commensurate with the extent of their participation in the activity.